Latest News

FDA approved | Image credit: Argus -
FDA Approves Tenth Adalimumab Biosimilar, Simlandi

February 24th 2024

After receiving 3 complete response letters, Alvotech has officially received US approval for its adalimumab biosimilar (AVT02; Simlandi), making it the first approval for the company, the tenth biosimilar to reference Humira, and the third interchangeable adalimumab biosimilar.

covid-19 vaccine | Image credit: Leigh Prather -
Adalimumab Treatment May Impact Antibody Levels After COVID-19 Vaccination

February 22nd 2024

eye on pharma banner
Eye on Pharma: VA Picks Hadlima; Biocon, Sandoz Partnership; A Stelara Settlement Abroad

February 21st 2024

syringe and vial | Image credit: Inna Dodor -
Summary of VOLTAIRE-X Study Explains Decision Behind Cyltezo Interchangeability

February 17th 2024

Dermatologist examining skin | Image Credit: fusssergei -
Biosimilar Candidate CT-P43 Shows Biosimilarity With Ustekinumab Originator in Plaque Psoriasis

February 13th 2024

Video Interviews
CFB podcast banner
CFB podcast banner

More News

© 2024 MJH Life Sciences

All rights reserved.